A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
The aim of the reported trial was to investigate the safety and efficacy of memantine in mild to moderate vascular dementia (VaD). This was a 28-week, double-blind, parallel, randomized controlled trial of memantine 20 mg daily versus placebo which was conducted in 54 centres in the UK. Memantine is...
Những tác giả chính: | Wilcock, G, Möbius, H, Stöffler, A |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2002
|
Những quyển sách tương tự
-
Memantine for the treatment of dementia.
Bằng: Wilcock, G
Được phát hành: (2003) -
Memantine for dementia.
Bằng: Mcshane, R, et al.
Được phát hành: (2006) -
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
Bằng: Hanney, M, et al.
Được phát hành: (2012) -
Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19
Bằng: Majed Al-Jeraisy, et al.
Được phát hành: (2021-04-01) -
A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease
Bằng: Kieburtz, K, et al.
Được phát hành: (2013)